Table 4 Relation between the molecular markers and the type of the enhancing lesions and the distribution of the lesion in MRI study (n = 80)
Molecular markers | Test of Sig | p | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luminal A (n = 37) | Luminal B HER2-negative (n = 19) | Luminal B HER2-positive (n = 12) | HER2-amplified (n = 4) | Triple-negative (n = 8) | ||||||||
No | % | No | % | No | % | No | % | No | % | |||
Distribution of the lesion | ||||||||||||
Single | 26 | 70.3 | 10 | 52.6 | 3 | 25.0 | 1 | 25.0 | 4 | 50.0 | χ2 = 12.762 | MCp = 0.076 |
Multifocal | 5 | 13.5 | 7 | 36.8 | 6 | 50.0 | 2 | 50.0 | 3 | 37.5 | ||
Multicentric | 6 | 16.2 | 2 | 10.5 | 3 | 25.0 | 1 | 25.0 | 1 | 12.5 | ||
MRI lesion type | ||||||||||||
Mass | 34 | 91.9 | 14 | 73.7 | 6 | 50.0 | 2 | 50.0 | 7 | 87.5 | χ2 = 14.826* | MCp = 0.021* |
Non-mass | 2 | 5.4 | 2 | 10.5 | 4 | 33.3 | 1 | 25.0 | 0 | 0.0 | ||
Mass + Non-mass | 1 | 2.7 | 3 | 15.8 | 2 | 16.7 | 1 | 25.0 | 1 | 12.5 | ||